Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Clinical trial NCT00374920 · COMPLETED

Trial details

NCT number: NCT00374920
Sponsor: Memory Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar Disorder With Manic or Mixed Episodes

Start date: 2006-09-01
Primary completion: 2006-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.